MoneyWorks4Me

The Total revenue for the quarter ended June 2022 of  Rs. 514.00 millions remain, more or less, the same.A slender decline of -28.35% was recorded to Rs. 38.67  millions from Rs. 53.97 millions in the corresponding previous quarter.Operating profit for the quarter ended June 2022 decreased to 64.66 millions as compared to 83.29 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 514.00 512.69 0.26 514.00 512.69 0.26 2196.63 2448.05 -10.27
Other Income 29.80 13.31 123.89 29.80 13.31 123.89 119.93 71.41 67.95
PBIDT 64.66 83.29 -22.37 64.66 83.29 -22.37 314.56 449.80 -30.07
Interest 5.04 1.89 166.67 5.04 1.89 166.67 13.55 2.71 400.00
PBDT 59.62 81.75 -27.07 59.62 81.75 -27.07 301.25 447.39 -32.67
Depreciation 9.95 9.71 2.47 9.95 9.71 2.47 39.48 40.35 -2.16
PBT 49.67 72.04 -31.05 49.67 72.04 -31.05 261.77 407.04 -35.69
TAX 11.00 18.07 -39.13 11.00 18.07 -39.13 63.86 115.32 -44.62
Deferred Tax 0.70 -0.06 -1266.67 0.70 -0.06 -1266.67 1.40 2.31 -39.39
PAT 38.67 53.97 -28.35 38.67 53.97 -28.35 197.91 291.72 -32.16
Equity 940.00 789.95 18.99 940.00 789.95 18.99 862.45 789.95 9.18
PBIDTM(%) 12.58 16.25 -22.57 12.58 16.25 -22.57 14.32 18.37 -22.06
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..